BUSINESS OVERVIEW
BenevolentAI (Euronext Amsterdam:BAI), a leader in applying advanced AI to accelerate drug discovery
BenevolentAI is a leading developer of advanced artificial intelligence technologies that unlock the value of multimodal data, surface novel insights, and accelerate biomedical discovery
Through the combined capabilities of its AI platform and scientific expertise, the Company is developing an inhouse drug pipeline of high-value assets. Headquartered in London (UK).
EMAIL ALERTS
Get alerts for our announcements
Investor events, conference attendance and annual reporting.